Ling Fu Selected Research

Ling Fu Research Topics

Disease

42	Neoplasms (Cancer) 01/2022 - 10/2004
11	Anthrax 09/2019 - 09/2004
9	Infections 01/2022 - 01/2011
6	Breast Neoplasms (Breast Cancer) 12/2016 - 07/2007
5	Virus Diseases (Viral Diseases) 12/2020 - 03/2005
4	COVID-19 01/2022 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 11/2013 - 08/2007
4	Carcinogenesis 07/2011 - 01/2006
3	Pain (Aches) 01/2022 - 05/2014
3	Melanoma (Melanoma, Malignant) 04/2020 - 06/2012
3	Carcinoma (Carcinomatosis) 06/2018 - 11/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2018 - 12/2005
3	Insulin Resistance 04/2008 - 08/2007
2	Wounds and Injuries (Trauma) 01/2022 - 11/2016
2	Rheumatoid Arthritis 01/2022 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 10/2021 - 04/2018
2	Body Weight (Weight, Body) 06/2021 - 10/2017
2	Communicable Diseases (Infectious Diseases) 06/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 04/2020 - 06/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 04/2014
2	Tetanus 04/2017 - 01/2016
2	Brucellosis (Malta Fever) 01/2017 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 07/2015 - 12/2012
2	Hepatocellular Carcinoma (Hepatoma) 04/2013 - 10/2004
2	Medulloblastoma 12/2012 - 09/2009
2	Plague (Bubonic Plague) 12/2009 - 02/2008
2	Fibrosis (Cirrhosis) 02/2007 - 01/2005
2	Lung Neoplasms (Lung Cancer) 01/2006 - 12/2005
2	Cataract (Cataracts) 03/2003 - 02/2002
1	Thrombosis (Thrombus) 05/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022
1	Osteoarthritis 01/2022
1	Wound Infection (Wound Infections) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2022
1	Tissue Adhesions 01/2022

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 01/2020 - 09/2004
13	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2003
10	Biomarkers (Surrogate Marker)IBA 01/2016 - 12/2005
9	Pharmaceutical PreparationsIBA 06/2021 - 04/2012
9	AntigensIBA 09/2019 - 08/2007
8	AntibodiesIBA 11/2016 - 09/2004
6	Messenger RNA (mRNA)IBA 12/2016 - 08/2009
5	Biological ProductsIBA 01/2022 - 02/2007
5	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 10/2004
5	anthrax toxin (anthrax lethal factor)IBA 11/2016 - 03/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2011
4	EpitopesIBA 02/2014 - 03/2006
4	AdiponectinIBA 08/2009 - 08/2007
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 05/2014
3	Monoclonal AntibodiesIBA 01/2020 - 11/2016
3	Anthrax Vaccines (Vaccines, Anthrax)IBA 09/2019 - 02/2014
3	Formaldehyde (Formol)FDA Link 06/2015 - 01/2014
3	ParaffinIBA 06/2015 - 01/2014
3	LigandsIBA 07/2014 - 01/2006
3	Adiponectin ReceptorsIBA 08/2009 - 08/2007
2	Reducing AgentsIBA 01/2022 - 07/2014
2	Complement System Proteins (Complement)IBA 01/2022 - 07/2007
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 03/2005
2	Angiotensin-Converting Enzyme 2IBA 01/2022 - 12/2020
2	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 11/2017
2	DiterpenesIBA 10/2021 - 11/2017
2	jaridon 6IBA 10/2021 - 11/2017
2	Tyrosine Kinase InhibitorsIBA 12/2018 - 04/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2018 - 12/2005
2	LuciferasesIBA 04/2018 - 11/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 10/2013
2	Cyclin D1IBA 11/2017 - 10/2004
2	Combined VaccinesIBA 04/2017 - 12/2009
2	Neutralizing AntibodiesIBA 11/2016 - 10/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2016 - 01/2014
2	RNA (Ribonucleic Acid)IBA 01/2016 - 11/2014
2	Estrogen ReceptorsIBA 11/2014 - 01/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014 - 12/2005
2	Antiviral Agents (Antivirals)IBA 08/2014 - 03/2011
2	Virulence Factors (Pathogenicity Factors)IBA 02/2014 - 05/2013
2	Rituximab (Mabthera)FDA Link 01/2014 - 03/2012
2	Phosphotransferases (Kinase)IBA 01/2013 - 01/2006
2	tyrosine receptor (receptor, tyrosine)IBA 01/2013 - 01/2006
2	HhAntag691IBA 12/2012 - 09/2009
2	CatecholaminesIBA 08/2009 - 08/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 08/2007
2	Crystallins (Crystallin)IBA 03/2003 - 02/2002
1	AnticoagulantsIBA 05/2022
1	Warfarin (Coumadin)FDA LinkGeneric 05/2022
1	Ketamine FDA LinkGeneric 01/2022
1	AlkaloidsIBA 01/2022
1	DisulfidesIBA 01/2022
1	(2R,3R,4R,5S)- 6- (((2S,3R,4R,5R)- 2,3,4,5,6- pentahydroxyhexyl)- (2- (4- (sulfanylmethyl)phenoxy)ethyl)amino)hexane- 1,2,3,4,5- pentolIBA 01/2022
1	HydrogelsIBA 01/2022
1	P-2165IBA 01/2022
1	bulleyaconitine AIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022

Therapy/Procedure

12	Therapeutics 05/2022 - 01/2006
3	Immunotherapy 11/2016 - 03/2006
3	Drug Therapy (Chemotherapy) 07/2015 - 12/2005
2	Precision Medicine 04/2020 - 01/2014
1	Intravenous Infusions 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Sutures (Suture) 01/2022